Delaware

White House Continues to Support Historically Black Colleges and Universities (HBCUs) by Glenda Glover, Ph.D., JD, CPA

Retrieved on: 
Thursday, October 14, 2021
Delaware State University, Goal, Government, Build Back Better Plan, Elementary and Secondary Education Act, Title III Part A, Tennessee, White House, Central Waqf Council, Administration, DOJ, Title-V Graduate Programs, Congress, White, Initiative, Color, Woman, American Rescue Plan Act of 2021, Delaware, Department, USS Jimmy Carter, HBCU, Taiwan, National, Policy, HEA, Education, White House Initiative on Asian Americans and Pacific Islanders, Office of the Vice President of the United States, Executive Office of the President of the United States, Multimedia, Health, Legislation, Student, Nursing, Higher Education Act, Violence, Investment, FY, Build Back Better, University, Master, Violence Against Women Act, Tennessee State University, Board, Climate, Research, List, COVID-19, Management, Pharmaceutical industry, Tutoring

As president of Tennessee State University, I see first-hand the difficulties that HBCUs experience and the continuing, looming disparity in the educational gap.

Key Points: 
  • As president of Tennessee State University, I see first-hand the difficulties that HBCUs experience and the continuing, looming disparity in the educational gap.
  • The President and Vice President have provided historic support for HBCUs and invested in HBCUs at unprecedented levels.
  • We must now work with Congress to pass the legislation that will more sustainably support HBCUs.
  • We all must continue to work with Congress to pass this legislation as it would indeed Build Back Better HBCUs.

Group of CytoDyn Stockholders Comments on Delaware Court Decision

Retrieved on: 
Thursday, October 14, 2021
Professional Services, Health, FDA, Legal, Finance, Pharmaceutical, Banking, Leadership, Participation, Leronlimab, DOJ, Edmonton Investors Group, Delaware, Security (finance), Delaware Court of Chancery, SEC, FDA, LLC, Nature, U.S. Securities and Exchange Commission, Company, Delaware Court, Auction

A group of long-time stockholders (the Investor Group) of CytoDyn Inc. (CYDY or the Company) that has nominated five highly experienced director candidates to serve on the Companys Board of Directors today commented on the decision made by the Delaware Court of Chancery to deny the Investor Groups request to force the Company to allow stockholders the opportunity to vote for the Investor Groups nominees.

Key Points: 
  • A group of long-time stockholders (the Investor Group) of CytoDyn Inc. (CYDY or the Company) that has nominated five highly experienced director candidates to serve on the Companys Board of Directors today commented on the decision made by the Delaware Court of Chancery to deny the Investor Groups request to force the Company to allow stockholders the opportunity to vote for the Investor Groups nominees.
  • The Investor Group stated: We believe strongly that the Courts ruling is fundamentally flawed and, as such, we are evaluating all possible alternatives.
  • This company is in desperate need of new leadership and oversight to enact sorely needed change.
  • All stockholders are advised to read the definitive proxy statement and other documents related to the solicitation of proxies.

Phoenix American Announces New Client Real Estate Fund Sponsor NAI Legacy

Retrieved on: 
Thursday, October 14, 2021
Solution, Industry, Ireland, Delaware, Delaware statutory trust, Phoenix American, NNN, Tenants in common 1031 exchange, Securitization, DST, Trauma surgery, Investment, Structured sale, SAN, Face, ABS, Partnership, CA, Airline, Financial services

SAN RAFAEL, Calif., Oct. 14, 2021 /PRNewswire/ -- Phoenix American is pleased to announce its new client partnership with real estate investment management firm NAI Legacy .

Key Points: 
  • SAN RAFAEL, Calif., Oct. 14, 2021 /PRNewswire/ -- Phoenix American is pleased to announce its new client partnership with real estate investment management firm NAI Legacy .
  • Phoenix American will support NAI Legacy with its industry-leading investor services platform featuring the STAR-XMS shareholder management / transfer agent system.
  • NAI Legacy is a full-service commercial real estate firm specializing in tax-efficient real estate investment solutions.
  • NAI Legacy is focused on commercial real estate investments, brokerage, net lease (NNN) properties, property management, asset management, and private client solutions.

Alpine 4 Holdings Announces That It Has Been Approved to List on The Nasdaq

Retrieved on: 
Thursday, October 14, 2021
Master of Business Administration, Technology, Facilitator, Indiana University Bloomington, Solution, Nasdaq, Treasurer, Intention, Director, Old National Bank, Delaware, Indiana University, Saint Joseph's College, SEC, Auburn University, Audit committee, ALPP, Business administration, Market for corporate control, University, Company, CEO, Bachelor of Business Administration, Delaware General Corporation Law, SVP, DSF, Board, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Management

Kent Wilson, CEO, had this to say about the Nasdaq approval: "This has been a long-anticipated event, and I can state enthusiastically that we are very pleased to be joining Nasdaq.

Key Points: 
  • Kent Wilson, CEO, had this to say about the Nasdaq approval: "This has been a long-anticipated event, and I can state enthusiastically that we are very pleased to be joining Nasdaq.
  • I want to say thank you to all our hard-working employees and shareholders who helped make this day possible!"
  • Mr. Zic has been with the Company since April 2020, originally serving as Corporate Controller.
  • By anchoring these words to the Company's combined experience and capabilities, Alpine 4 can aggressively pursue opportunities within and across vertical markets.

Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid

Retrieved on: 
Thursday, October 14, 2021
Oncology, AIDS, Health, Infectious Diseases, Clinical Trials, Pharmaceutical, Biotechnology, NUALS Arts and Literary Annual Meet, OTCQB, XV, Director, Lavender Hill Mob (gay activist group), Compliance, BLA, FDA, NASH, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, THE, Forward-looking statement, Annual report, HIV, CCTV, Clinical trial, Patient, Activism, Food, Company, Standard of care, Board, Risk, Viral load, Beneficial ownership, 100,000, Delaware, Security (finance), Proxy, Optimism, SEC, Triple-negative breast cancer, Court, Social conditions in Honduras, Food and Drug Administration Amendments Act of 2007, Annual general meeting, Vaccine, SARS, Suite, Judgement, Delaware Court, U.S. Securities and Exchange Commission, COVID-19, Name, CCR5, Delaware Court of Chancery, Form 10-K, Calendar, Main Street, Partnership, Sidley Austin, Pharmaceutical industry, Lease, Auction, Animal

All of the Activist Groups claims were denied and judgment was entered for CytoDyn and its Board.

Key Points: 
  • All of the Activist Groups claims were denied and judgment was entered for CytoDyn and its Board.
  • IncellDx: The Board legitimately suspected that Patterson and others were keen on revisiting the failed attempt to combine IncellDx and CytoDyn.
  • The Court therefore concluded that the nomination notice was fatally incomplete and that the Board of Directors was justified in rejecting it.
  • Scott A. Kelly, M.D., Chairman of the Board of CytoDyn, stated, Our by-laws are in place to ensure that all shareholders are treated equally.

Asset Management Veteran Robert Nestor Named Global Senior Advisor for Qraft Technologies

Retrieved on: 
Tuesday, October 12, 2021
Professional Services, Data Management, Technology, Software, Finance, Networks, Consulting, Prospectus, ETF, NYSE Arca, Risk, Science and technology in Asia, LLC, California Managed Risk Medical Insurance Board, NVQ, Direxion, HDIV, BlackRock, MBA, Funding, CFA, Alpha, Industry, Marketing, Drexel University, Adoption, Artificial intelligence, University, Bachelor of Science, Delaware, Fund, Vanguard, Lovell Minnick Partners, Risk management, Solution, Nestor, Research, Technology, Economics, Management, Financial adviser, Security (finance)

AI-enabled fintech company Qraft Technologies (Qraft) announced that Robert Nestor, CFA, will join the firm as a Global Senior Advisor.

Key Points: 
  • AI-enabled fintech company Qraft Technologies (Qraft) announced that Robert Nestor, CFA, will join the firm as a Global Senior Advisor.
  • Nestor has served in a variety of senior leadership roles in asset management over his career most recently as president and head of Direxion ETFs.
  • I see these technologies as a driving force for asset management and thoughtful risk management that will become increasingly relevant as markets become more volatile.
  • We feel privileged to welcome Rob aboard Qraft Technologies, says Marcus Kim, Founder and Chief Executive Officer for Qraft Technologies.

QAD Inc. Announces Intention to Adjourn Special Meeting of Stockholders to November 2

Retrieved on: 
Tuesday, October 12, 2021
Other Manufacturing, Technology, Transport, Software, Manufacturing, Networks, Data Management, Logistics, Supply Chain Management, Supply Chain Management, Retail, Private Securities Litigation Reform Act, Company, Twitter, 100,000, Forward-looking statement, Risk, Delaware Court, Special, XXV, Tripura Merger Agreement, PST, LLC, QMS, List, COVID-19, Motion, Innovation Place Research Park, Name, Marketing, LinkedIn, Pinterest, QAD, Annual report, Securities Exchange Act of 1934, SEC, Pressure, Instagram, U.S. Securities and Exchange Commission, Hearing, Delaware, Communication, ERP, Maintenance, Securities Act of 1933, Pandemic, Security (finance), Thoma Bravo, DSCP, QAD Inc., Acquisition, Vii, Delaware Court of Chancery, Court, Food, Technology, Reading, Cryptocurrency

The Company intends to reconvene the Special Meeting on Tuesday, November 2, 2021, at 8:00 a.m. PST, at the QAD corporate headquarters located at 100 Innovation Place, Santa Barbara, California.

Key Points: 
  • The Company intends to reconvene the Special Meeting on Tuesday, November 2, 2021, at 8:00 a.m. PST, at the QAD corporate headquarters located at 100 Innovation Place, Santa Barbara, California.
  • The record date for stockholders entitled to vote at the Special Meeting remains September 7, 2021, and no changes have been made to the proposals to be voted on by stockholders at the Special Meeting.
  • Stockholders who have previously cast their votes do not need to vote again unless they want to change their vote.
  • QAD is a registered trademark of QAD Inc. All other products or company names herein may be trademarks of their respective owners.

Ensoma Appoints Cell and Gene Therapy Pioneer Emile Nuwaysir, Ph.D., as Chief Executive Officer

Retrieved on: 
Monday, October 11, 2021
Biotechnology, Pharmaceutical, Genetics, Health, Lists of diseases, Autoimmunity, Therapy, Takeda, National, Roche, Severin Schwan, IPO, Fujifilm, Engineering, Roche Diagnostics, Time-invariant system, Cell, Bluerock Creek, Blood, Cancer, Industry, Doctor of Philosophy, CDI, Bayer, University of Wisconsin–Madison, University, Cellular Dynamics International, Delaware, University of North Carolina at Chapel Hill, Immune system, Chapel Hill, CEO, Medicine, Partnership, Acquisition, Patient, Regenerative medicine, Nasdaq, Management, Vaccine

Ensoma, a gene therapy company advancing the future of medicine through precision in vivo engineering of blood and immune cells, today announced the appointment of Emile Nuwaysir, Ph.D., as president, chief executive officer and member of the companys board of directors.

Key Points: 
  • Ensoma, a gene therapy company advancing the future of medicine through precision in vivo engineering of blood and immune cells, today announced the appointment of Emile Nuwaysir, Ph.D., as president, chief executive officer and member of the companys board of directors.
  • Dr. Nuwaysir is currently the chairman of the Alliance for Regenerative Medicine, an international advocacy organization comprised of 400+ member companies dedicated to advancing cell and gene medicines.
  • Prior to BlueRock, Dr. Nuwaysir served as president and chief operating officer of Cellular Dynamics International (CDI), A Fujifilm Company.
  • Ensoma is supported by top-tier investors, a strategic collaboration with Takeda and a passionate team committed to a bold, global vision for gene therapy.

Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent

Retrieved on: 
Friday, October 8, 2021
NASDAQ, Private Securities Litigation Reform Act, NDA, Inter partes review, Patent, Trial of the century, Therapy, LLC, Douglas v. U.S. District Court ex rel Talk America, Endpoint security, COVID-19, Temperature, IPR, Goal, District, GLOBE, Safety, PTAB, Pulmonary hypertension, Industry, INSPIRE, District court, SEC, Lung, Pharmacology, FDA, Review, Orange Book, Delaware, Lesbian flag, USPTO, UTC, New Drug Application, Coronavirus, Hypertensive emergency, Patient, PAH, Environment, Pharmaceutical industry, Generic drug

9,604,901 (901 patent) owned by United Therapeutics Corporation (UTC) and listed in the Orange Book for Tyvaso (treprostinil inhalation solution).

Key Points: 
  • 9,604,901 (901 patent) owned by United Therapeutics Corporation (UTC) and listed in the Orange Book for Tyvaso (treprostinil inhalation solution).
  • Damian deGoa, President and Chief Executive Officer of Liquidia said: We are very pleased with this decision by the PTAB.
  • This is a clear win in our on-going patent dispute with United Therapeutics, and we remain confident that we will ultimately prevail on all patent claims they have asserted against us.
  • The PTABs decision with respect to the 901 patent does not resolve the on-going litigation brought by UTC related to LIQ861.

Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders

Retrieved on: 
Friday, October 8, 2021
Gene silencing, Twitter, Tumor microenvironment, Forward-looking statement, Annual Meetings of the International Monetary Fund and the World Bank Group, Proxy, Delaware Court, Sirna, GLOBE, Therapure BioPharma Inc, U.S. Securities and Exchange Commission, Sutro Biopharma, Delaware, Communication, TLR9, Immunotherapy, TLR, RNA, Acquisition, Delaware Court of Chancery, Nasdaq, Annual general meeting

The adjourned meeting will be held by means of remote communication and can be accessed via the following URL: http://www.cesonlineservices.com/scps21_vm .

Key Points: 
  • The adjourned meeting will be held by means of remote communication and can be accessed via the following URL: http://www.cesonlineservices.com/scps21_vm .
  • The record date for the Annual Meeting will remain August 16, 2021.
  • Scopus continues to solicit votes from its stockholders with respect to the proposals set forth in Scopus proxy statement dated September 16, 2021.
  • Proxies previously submitted in respect of the Annual Meeting will be voted at the adjourned Annual Meeting unless properly revoked, and stockholders who have previously submitted a proxy or otherwise voted and who do not want to change their vote need not take any action.